Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $110 Million
- Q4 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 254,794 shares of NTRA stock, worth $41.4 Million. This represents 36.7% of its overall portfolio holdings.
Number of Shares
254,794
Previous 291,094
12.47%
Holding current value
$41.4 Million
Previous $37 Million
9.01%
% of portfolio
36.7%
Previous 32.53%
Shares
14 transactions
Others Institutions Holding NTRA
# of Institutions
634Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$2 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.09 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.09 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$719 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...